C. Scoditti (Mesagne, Italy), A. Olin (Gothenburg, Sweden)
Impact of checklist proforma on discharge and follow up care of patients admitted with COPD exacerbations
M. Murthy, R. Sarkar, H. Metcalfe, S. Taylor, G. Jones, J. Bayliss, R. Stead, M. Babores (Macclesfield, United Kingdom)
|   |
COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations
Z. I. Fratila, I. Iovan, D. Vancea (Timisoara, Romania)
| |
Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score
C. Pothirat, W. Chaiwong, A. Limsukon, A. Deesomchok, C. Liewsrisakul, C. Bumroongkit (Chiang Mai, Thailand)
| |
Use of COPD assessment (CAT) test in monitoring acute exacerbations
I. Shafiq, K. Huggett, L. Idris, B. Rudran, T. Shaw (Bournemouth, United Kingdom)
| |
Evaluation of high-sensitivity C-reactive protein in acute asthma
E. Razi, H. Ehteram, H. Akbari, V. Chavoshi, A. Razi (Kashan, Tehran, Islamic Republic Of Iran)
| |
Effects of home oximetry on chronic obstructive pulmonary disease exacerbations
M. Y. Chew, T. K. Lim, P. Chong, M. Tang, C. Lim (Singapore, Singapore)
| |
Clinical validity of blood and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
J. Huang, R. Chaudhuri, A. Barton, J. Brady, C. Grierson, O. Albarbarawi, P. Rauchhaus, C. Weir, M. Messow, C. McSharry, G. Feuerstein, S. Mukhopadyhay, C. Palmer, D. Miller, N. Thomson (Dundee, Glasgow, United Kingdom; Collegeville, United States Of America)
| |
Clinical and functional assessment according to the exacerbating phenotype in COPD
V. Almadana, A. Valido, R. Tallón, J. Sánchez, C. Romero, T. Montemayor (Sevilla, Spain)
| |
The number of exacerbations in children and adolescents with cystic fibrosis (CF) can be predicted by computed tomography (CT) bronchiectasis (BE) score and quality of life scores
L. Tepper, E. Utens, A. Quittner, K. Gonzalez-Graniel, H. Duivenvoorden, H. Tiddens (Rotterdam, Netherlands; Miami, United States Of America)
| |
Factors determining duration of hospital stay in patients hospitalized for acute COPD exacerbation
F. Diamantea, S. Tsikrika, F. Karakontaki, D. Mitromaras, E. Stagaki, E. Kastanakis, V. Polychronopoulos (Athens, Greece)
| |
VentCheck: Spot measurement of combined oximetry & cutaneous carbon dioxide to screen for type II respiratory failure in respiratory illness
P. Chaudhari, A. Kate, F. Baty, J. Leuppi, P. Chhajed (Mumbai, NaviMumbai, India)
| |
Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans
P. J. Honkoop, D. R. Taylor, J. B. Snoeck-Stroband, J. K. Sont (Leiden, Netherlands; Dunedin, New Zealand)
| |
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline
F. L. Dente, F. Novelli, M. L. Bartoli, M. Carli, S. Cianchetti, A. Di Franco, E. Bacci, P. L. Paggiaro (Pisa, Italy)
| |
Correlation of dyspnea and physiological impairment in COPD exacerbation
T. Cvok, B. Milenkovic, P. Rebic (Belgrade, Republic Of Serbia)
| |
Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD
A. Papadopoulos, K. Bartziokas, A. Haniotou, K. Kostikas (Athens, Greece)
| |
Patient experiences of exacerbations in a real world setting: Global results from the Hidden Depths survey
N. Barnes, P. M. A. Calverley, A. Kaplan, K. F. Rabe (London, Liverpool, United Kingdom; Ontario, Canada; Grosshansdorf, Germany)
| |
Impact of climate change on COPD in Berlin-Brandenburg – Developing a telemonitoring based approach for early intervention
N. Döhnert, M. Haug, U. Liebers, F. Köhler, R. Kreutz, G. Schönfelder, M. Langner, W. Endlicher, C. Witt (Berlin, Germany)
| |
Sputum biomarkers in COPD exacerbations
S. Soter, I. Barta, B. Antus (Budapest, Hungary)
| |